Clinical Scorecard: DRY EYE: Bolstering the tear film
At a Glance
| Category | Detail |
|---|---|
| Condition | Dry Eye Disease (DED) |
| Key Mechanisms | Compromise of the lacrimal functional unit affecting tear secretion. |
| Target Population | Contact lens wearers experiencing discomfort due to dry eye. |
| Care Setting | Ophthalmology practices and specialty dry eye clinics. |
Key Highlights
- Dry eye disease decreases contact lens tolerability.
- Improving tear film is essential for long-term contact lens wear.
- Meibomian gland dysfunction is prevalent in 30% to 60% of contact lens wearers.
- Multiple treatment options are available to enhance tear volume and lipid layer.
- Reducing toxic load from contact lens solutions can alleviate symptoms.
Guideline-Based Recommendations
Diagnosis
- Assess ocular surface issues and symptoms of dry eye disease.
Management
- Utilize medications such as cyclosporine and liftegrast to increase tear volume.
- Implement at-home therapies like warm compresses and eyelid hygiene.
Monitoring & Follow-up
- Regularly evaluate contact lens wear time and comfort.
Risks
- Toxicity from contact lens solutions can exacerbate dry eye symptoms.
Patient & Prescribing Data
Patients with dry eye disease who wear contact lenses.
Consider both pharmacological and non-pharmacological interventions to manage symptoms.
Clinical Best Practices
- Encourage daily disposable lenses and preservative-free care systems.
- Educate patients on the importance of maintaining a healthy tear film.
- Monitor for meibomian gland dysfunction and address it promptly.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
